Both in Pharmaceuticals
Ovid Therapeutics vs Assembly Biosciences
Over the past year OVID returned +81.4% and ASMB returned −4.7%; their daily moves had a correlation of 0.20.
OVID +81.4% ASMB −4.7%Growth of $1, one year, split-adjusted
| Metric | OVID | ASMB |
|---|---|---|
| Price | $2.54 | $23.48 |
| Market cap | $496.1M | $478.1M |
| Today | +3.25% | −0.55% |
| 1 month | −9.3% | −31.1% |
| 6 months | +20.4% | −11.9% |
| Year to date | +55.8% | −31.0% |
| 1 year | +46.8% | −4.8% |
| Revenue growth (YoY) | −88.3% | +38.9% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −2047.6% | −28.8% |
| P/E (TTM) | — | — |
| Price / sales | 313.4× | 6.4× |
| Net cash | $117.2M | $320.4M |
| Dividend yield | — | — |
| Volatility (60d) | 51.8% | 61.3% |
| Short % of float | 13.4% | 19.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).